Pharma Equity Group A/S (CPH:PEG)

Denmark flag Denmark · Delayed Price · Currency is DKK
0.1200
+0.0015 (1.27%)
Jul 25, 2025, 4:59 PM CET
1.27%
Market Cap145.46M
Revenue (ttm)n/a
Net Income (ttm)-24.42M
Shares Out1.23B
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume150,237
Average Volume377,354
Open0.1185
Previous Close0.1185
Day's Range0.1180 - 0.1200
52-Week Range0.0706 - 0.3130
Beta0.89
RSI50.64
Earnings DateAug 14, 2025

About Pharma Equity Group

Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement. Its products under development that are in Phase II clinical trials include RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of Ulcus Cruris chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouch... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Denmark
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol PEG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.